Glenmark Pharmaceuticals
BSE: 532296 | NSE: GLENMARK | ISIN: INE935A01035 | SECTOR: Biotechnology & DrugsRatios
- Management Effectiveness
- Margins
- Financial Strength
- Valuation
- Income Statement
- Growth
- Per Share Data
- Price and Volume
Return on average equity - 5 year average
9.74Net Income/employee - trailing 12 month
-7,33,926.40Revenue/employee - most recent fiscal year
74,80,053.00Return on investment - most recent fiscal year
-0.68Return on average assets - most recent fiscal year
-0.49Receivables turnover - most recent fiscal year
3.42Return on investment - trailing 12 month
-Return on average assets - trailing 12 month
-Inventory turnover - most recent fiscal year
1.69Inventory turnover - trailing 12 month
-Revenue/employee - trailing 12 month
75,53,779.00Return on average assets - 5 year average
4.65Net Income/employee - most recent fiscal year
-57,835.39Return on average equity - trailing 12 month
-Receivables turnover - trailing 12 month
-Asset turnover - most recent fiscal year
0.64Asset turnover - trailing 12 month
-Return on average equity - most recent fiscal year
-1.83Return on investment - 5 year average
6.46